A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene
NCT04395677
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
173
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
AB-106
Sponsor
Nuvation Bio Inc.